Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?
Name: Susan Stark
Year: 2022
Reference:
Kehrer-Dunlap A, Bollinger R, Chen S-W, Keleman A, Thompson R, Fagan A, Ances B. Higher amyloid correlates to greater loneliness during the COVID-19 pandemic. F1000Research; undergoing peer review.
Name: Peter Millar
Year: 2022
Reference:
Millar, PR, Luckett, PH, Gordon, BA, Benzinger, TLS, Schindler, SE, Fagan, AM, Cruchaga, C, Bateman, RJ, …, the Dominantly Inherited Alzheimer Network, Morris, JC, & Ances, BM (2022). Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease. NeuroImage, 256, 119228. DOI: 10.1016/j.neuroimage.2022.119228 PMID: 35452806.
Millar, PR, Gordon, BA, Luckett, PH, Benzinger, TLS, Cruchaga, C, Fagan, AM, Hassenstab, JJ, Perrin, RJ, Schindler, SE, …, the Dominantly Inherited Alzheimer Network, Bateman, RJ, Morris, JC, & Ances, BM (submitted). Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages.
Name: Anne Fagan
Year: 2022
Reference:
O’Connor A, Rice H, Barnes J, Ryan NS, Liu KY, Allegri RF, Berman S, Ringman JM, Cruchaga C, Farlow MR, Hassenstab J, Lee JH, Perrin RJ, Xiong C, Gordon B, Levey AI, Goate A, Graff-Radford N, Levin J, Jucker M, Benzinger T, McDade E, Mori H, Noble JM, Schofield PR, Martins RN, Salloway S, Chhatwal J, Morris JC, Bateman R, Howard R, Reeves S, Fox NC; Dominantly Inherited Alzheimer Network. First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study. J Neurol Neurosurg Psychiatry. 2022 Dec 15:jnnp-2022-329843. doi: 10.1136/jnnp-2022-329843. Epub ahead of print. PMID: 36522155.
Name: Suzanne Schindler
Year: 2022
Reference:
Rosen AC, Arias JJ, Ashford JW, Blacker D, Chhatwal JP, Chin NA, Clark L, Denny SS, Goldman JS, Gleason CE, Grill JD, Heidebrink JL, Henderson VW, Lavacot JA, Lingler JH, Menon M, Nosheny RL, Oliveira FF, Parker MW, Rahman-Filipiak A, Revoori A, Rumbaugh MC, Sanchez DL, Schindler SE, Schwarz CG, Toy L, Tyrone J, Walter S, Wang LS, Wijsman EM, Zallen DT, Aggarwal NT. The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All. J Alzheimers Dis. 2022 Jul 31. PMID: 35938255.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK, Ashton NJ, Henson RL, Yarasheski KE, West T, Meyer MR, Kirmess KM, Li Y, Saef B, Moulder KL, Bradford D, Fagan AM, Gordon BA, Benzinger TLS, Balls-Berry J, Bateman RJ, Xiong C, Zetterberg H, Blennow K, Morris JC. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light. Neurology. 2022 Apr 21. PMID: 35450967.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK. Comorbidities confound Alzheimer’s blood tests. Nature Med. 2022 Jul 4. PMID: 35788176.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK. “Comorbidities confound Alzheimer’s blood tests.” Nature Med. (2022). Schindler, S.E., Karikari, T.K. Comorbidities confound Alzheimer’s blood tests. Nature Med (2022). https://doi.org/10.1038/s41591-022-01875-3.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Li Y, Li M, Despotis A, Park E, Vittert L, Hamilton BH, Womack KB, Saef B, Holtzman DM, Morris JC, Bateman RJ, Gupta MR. Using Alzheimer’s disease blood tests to accelerate clinical trial enrollment. Alzheimers Dement. 2022 Aug 7. PMID: 35934777
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Ney DE, Goss AL, Rabinovici G. “ANA Investigates: The Future of Biomarkers in Alzheimer Disease.” Ann Neurol. June 2022; https://doi.org/10.1002/ana.26437.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE. Predicting Symptom Onset in Sporadic Alzheimer’s Disease: “How Long Do I Have?” J Alzheimers Dis. 2022 Feb 21. PMID: 35213383
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE. “Fluid biomarkers in dementia diagnosis.” CONTINUUM Lifelong Learning in Neurology. 2022 June; 28(3):822-833. DOI: 10.1212/CON.0000000000001083.
Name: Marissa Streitz
Year: 2022
Reference:
Streitz ML, Denny A, Xiong C, et al. Development of a Comprehensive Battery to Collect Social and Structural Determinants of Health (SSDOH) in Cognitively Normal or Very Mildly Impaired Persons. Alzheimer Dis Assoc Disord. 2022;36(2):97-102. doi:10.1097/WAD.0000000000000505
Name: Anne Fagan
Year: 2022
Reference:
Wang G, Li Y, Xiong C, McDade E, Clifford DB, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Libre-Guerra JJ, McCullough A, Joseph-Mathurin N, Chen CD, Mummery C, Wendelberger BA, Gauthier S, Masellis M, Holdridge KC, Yaari R, Chatterjee S, Sims J, Delmar P, Kerchner GA, Bittner T, Hofmann C, Bateman RJ; DIAN‐TU Study Team. Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease. Alzheimers Dement (Amst). 2022 Nov 3;14(1):e12367. doi: 10.1002/dad2.12367. PMID: 36348972; PMCID: PMC9632865.
Name: Suzanne Schindler
Year: 2022
Reference:
Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA, Baratta M, Kolb HC, Dobler I, Mordashova Y, Saad ZS, Raunig DL, Spanakis EM, Li Y, Schindler SE, Ferber K, Rubel CE, Martone RL, Weber CJ, Edelmayer RM, Meyers EA, Bollinger JG, Rosenbaugh EG, Potter WZ; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer’s Disease Project Team. Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity. Alzheimers Dement. 2022 Jul 12. PMID: 35820077.
Name: Cyrus Raji
Year: 2021
Reference:
Amjad Samara 1, Zhaolong Li 1 2, Jerrel Rutlin 1, Cyrus A Raji 3 4, Peng Sun 3, Sheng-Kwei Song 3, Tamara Hershey 1 3 4, Sarah A Eisenstein 1 3
Nucleus accumbens microstructure mediates the relationship between obesity and eating behavior in adults
Obesity (Silver Spring)
. 2021 Jul 5. doi: 10.1002/oby.23201. Online ahead of print.
PMID: 34227242 DOI: 10.1002/oby.23201
Name: Ganesh Babulal
Year: 2021
Reference:
Babulal GM. Inclusion of ethnoracial populations and diversity remains a key challenge in Alzheimer’s disease biofluid-based biomarker studies. Journal of the Neurological Sciences. 2021; 421:117269. PMID: 33357998
Name: Suzanne Schindler
Year: 2021
Reference:
Boerwinkle AH, Wisch JK, Chen CD, Gordon BA, Butt OH, Schindler SE, Sutphen C, Flores S, Dincer A, Benzinger TLS, Fagan AM, Morris JC, Ances BM. Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease. Neurology. 2021 Apr 30. PMID: 33931538.
Name: Suzanne Schindler
Year: 2021
Reference:
Butt OH, Long JM, Henson RL, Herries E, Sutphen CL, Fagan AM, Cruchaga C, Ladenson JH, Holtzman DM, Morris JC, Ances BM, Schindler SE. Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25. Neurobiol Aging. 2021 Feb 11;102:64-72. PMID: 33765432.
Name: Suzanne Schindler
Year: 2021
Reference:
Li Y, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Weiner MW, Leslie SM, Masters CL, Fowler CJ, Trojanowski JQ, Korecka M, Martins RN, Janelidze S, Hansson O, Bateman RJ. Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology. 2021 Dec 14:10.1212/WNL.0000000000013211
PMCID: PMC8865895
Name: Jingqin Luo
Year: 2021
Reference:
Luo J, Gao F, Liu J, Wang G, Chen L, Fagan AM, Day GS, Vöglein, Chhatwal JP, Xiong C & the Dominantly Inherited Alzheimer Network. Statistical Estimation and Comparison of Group-Specific Bivariate Correlation Coefficients in Family-type Clustered Studies. Journal of Applied Statistics. NIHMS1687855.
Name: Cyrus Raji
Year: 2021
Reference:
Maria Ly 1, Cyrus A Raji 2 3, Gary Z Yu 1, Qing Wang 2, Yong Wang 2, Suzanne E Schindler 3, Hongyu An 2, Amjad Samara 4, Sarah A Eisenstein 2 4, Tamara Hershey 2 3 4 5, Gordon Smith 6, Samuel Klein 6, Jingxia Liu 7, Chengjie Xiong 7, Beau M Ances 3, John C Morris 3, Tammie L S Benzinger 2 Obesity and White Matter Neuroinflammation Related Edema in Alzheimer’s Disease Dementia Biomarker Negative Cognitively Normal Individuals J Alzheimers Dis
. 2021;79(4):1801-1811. doi: 10.3233/JAD-201242. PMID: 33459647 DOI: 10.3233/JAD-201242
Name: Suzanne Schindler
Year: 2021
Reference:
Meeker KL, Butt OH, Gordon BA, Fagan AM, Schindler SE, Morris JC, Benzinger TLS, Ances BM. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage. Neurobiol Dis. 2022 Feb 12;:105662. PMID: 35167933.
Name: Jonathan Kipnis
Year: 2021
Reference:
Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy.
Da Mesquita S, Papadopoulos Z, Dykstra T, Brase L, Farias FG, Wall M, Jiang H, Kodira CD, de Lima KA, Herz J, Louveau A, Goldman DH, Salvador AF, Onengut-Gumuscu S, Farber E, Dabhi N, Kennedy T, Milam MG, Baker W, Smirnov I, Rich SS; Dominantly Inherited Alzheimer Network, Benitez BA, Karch CM, Perrin RJ, Farlow M, Chhatwal JP, Holtzman DM, Cruchaga C, Harari O, Kipnis J.
Nature. 2021 May;593(7858):255-260. doi: 10.1038/s41586-021-03489-0. Epub 2021 Apr 28.
PMID: 33911285
Name: Peter Millar
Year: 2021
Reference:
Millar, PR, Ances, BM, Gordon, BA, Benzinger, TLS, Morris, JC, & Balota, DA (2021). Evaluating cognitive relationships with resting-state and task-driven BOLD variability. Journal of Cognitive Neuroscience, 33 (2), 279-302. DOI: 10.1162/jocn_a_01645 PMCID: PMC7877897 PMID: 33135966.
Name: Samantha Murphy
Year: 2021
Reference:
Murphy SA, Babulal GM, Roe CM. The Importance of Advancing Research on Aging and Driving. Geriatrics. 2021; 6(1):7. https://doi.org/10.3390/geriatrics6010007